Zoetis logo

ZoetisNYSE: ZTS

Profile

Sector:

Healthcare

Country:

United States

IPO:

01 February 2013

Next earnings report:

04 November 2024

Last dividends:

18 July 2024

Next dividends:

31 October 2024
$81.07 B
-30%vs. 3y high
98%vs. sector
-41%vs. 3y high
58%vs. sector
-35%vs. 3y high
95%vs. sector
-40%vs. 3y high
74%vs. sector

Price

regular market | 6 min ago
$178.94-$3.35(-1.84%)
$2.36 B$2.29 B
$2.36 B$624.00 M

Analysts recommendations

Institutional Ownership

ZTS Latest News

Zoetis Gears Up to Report Q3 Earnings: What's in the Offing?
zacks.com29 October 2024 Sentiment: POSITIVE

ZTS' increased sales of companion animal products probably boosted revenues in the third quarter of 2024 for both the U.S. and international markets.

Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth
zacks.com28 October 2024 Sentiment: POSITIVE

Zoetis (ZTS) has the right mix of factors that could lead to a strong earnings report soon. Be ready for the important expectations.

Zoetis Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Take Part
accesswire.com26 October 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / October 26, 2024 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.

Will Zoetis (ZTS) Beat Estimates Again in Its Next Earnings Report?
zacks.com21 October 2024 Sentiment: POSITIVE

Zoetis (ZTS) has a strong track record of surprising with its earnings and currently has the right mix of factors that suggest it may exceed expectations in its upcoming quarterly report.

Zoetis Inc Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Take Part
accesswire.com20 October 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / October 20, 2024 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements and/or did not share important information with investors.

Investors Are Encouraged To Join The Schall Law Firm's Inquiry Into Zoetis Inc. For Securities Law Violations
accesswire.com19 October 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / October 19, 2024 / The Schall Law Firm, a national firm specializing in shareholder rights, is looking into claims for investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements and/or did not share important information with investors.

Zoetis Inc Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Urges Shareholder Participation
accesswire.com12 October 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.

Zoetis Declares Fourth Quarter 2024 Dividend
businesswire.com10 October 2024 Sentiment: POSITIVE

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) has announced a dividend of $0.432 per share for the fourth quarter of 2024. This payment will be made on Tuesday, December 3, 2024, to all shareholders who own the company's common stock as of the end of business on Thursday, October 31, 2024. Zoetis is the leading company in animal health, focused on improving care for animals and supporting human well-being.

Zoetis: A Solid Choice For The Young Dividend Growth Investor
seekingalpha.com09 October 2024 Sentiment: POSITIVE

Zoetis is known for its innovative approach, developing new categories and improving care standards, which helps it outperform its rivals. The company shows careful management of its finances by making strategic investments and selling off less profitable areas, leading to ongoing growth. With its strong market position, growth potential, and attractive dividends, ZTS is a good choice for young investors looking for dividend growth.

The Schall Law Firm Urges Shareholder Participation In An Investigation Into Zoetis Inc For Possible Securities Fraud
accesswire.com08 October 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / October 8, 2024 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.

What type of business is Zoetis?

Zoetis Inc. is an American pharmaceutical company headquartered in Parsippany, New Jersey, specializing in the development, production, and sale of veterinary medicines, vaccines, and diagnostic products for the livestock and pets industry. It was founded in 2012 as a spin-off from the largest drug manufacturer, Pfizer Inc. The company is one of the largest in its industry. Its main competitive advantages include: an extensive network of technical and veterinary operations specialists, high-quality production and reliable supply, years of experience, strong customer relationships, ongoing research and development (R&D), and more.

What sector is Zoetis in?

Zoetis is in the Healthcare sector

What industry is Zoetis in?

Zoetis is in the Drug Manufacturers - Specialty & Generic industry

What country is Zoetis from?

Zoetis is headquartered in United States

When did Zoetis go public?

Zoetis initial public offering (IPO) was on 01 February 2013

What is Zoetis website?

https://www.zoetis.com

Is Zoetis in the S&P 500?

Yes, Zoetis is included in the S&P 500 index

Is Zoetis in the NASDAQ 100?

No, Zoetis is not included in the NASDAQ 100 index

Is Zoetis in the Dow Jones?

No, Zoetis is not included in the Dow Jones index

When was Zoetis the previous earnings report?

No data

When does Zoetis earnings report?

The next expected earnings date for Zoetis is 04 November 2024